Doctors, nurses, police may use hydroxychloroquine to prevent corona

New Delhi, 23rd May 2020 Saturday

The Indian Council of Medical Research (ICMR) has had great success in the use of hydroxychloroquine. ICMM Three types of extensive research studies conducted by have shown that hydrochloroquine (HCQ) is highly effective in preventing covid-12 infection.

ICMR sources said doctors, nurses and other medical personnel treating patients with corona may take HSQ doses for their safety. Thus the H.S.Q. Used in the treatment of malaria. However, in the current worrying circumstances, in addition to medical personnel, police, paramilitary forces and other security guards can also take a dose of HCQ. In addition, medical personnel treating patients other than Kovid-12 can also take this drug.

ICMR By HCQ. Special guidelines on the use of no. This guide states that HCQ There have been various criticisms and protests about the use of. Because there has been no accurate scientific research on the use of this drug. Simultaneously HCQ. The use of no is also discussed to cause some side effects. However, we have experimented with ginger on 12 health works. Our study found that only 2.7 percent of medical staff had symptoms of nausea, 2.7 percent had mild abdominal pain, 1.3 percent had vomiting, 1.3 percent had low blood pressure, and 1.7 percent had mild heart failure. Have been found.

However, the sources also clarified that if the use of HCQ appears to have side effects in activities like cardiomyopathy (difficulty in sending blood to the whole body to the heart), then we will stop using this drug.

Case escalating drug shortage

Hydroxyclaroquine (HCQ), an anti-malarial pill used to treat patients with Covid-12, is becoming a major problem in the metropolis.

To address this problem, the Food and Drug Administration (FDA) authorities recently met with HCQ manufacturers and instructed them to increase production of the pill. It is worth mentioning that HCQ is currently considered as a weapon in the fight against Corona.

In India, the ICMR (Indian Council of Medical Research) has approved HCQ as a prophylactic for all health workers treating patients with COVID-12, as well as for families who come in contact with COVID-positive patients.

The Maharashtra government in a notification issued in the last week of April recommended giving HCQs to health workers and employees, municipal employees and quarantine centers, coronary patients and people associated with the containment zone under proper guidance.

The president of the Association of Medical Consultants (AMC), Dr. Deepak B Day said there has been a huge demand for HCQ for the last two weeks. As a result, it has run out of stock in private nursing homes and medical stores. It has happened many times that we have not been able to give this pill to Kovid's patient as it is not available.

Demand for this specialty has grown significantly as a result of recent corporate scandals. We have asked manufacturers to increase their production. Said an FDA official.